A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy

MLA

Qunfang Yang, et al. “A Nanoformulation for Immunosuppression Reversal and Broad-Spectrum Self-Amplifying Antitumor Ferroptosis-Immunotherapy.” Biomaterials, vol. 292, Oct. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f66ad1ab4f54129408c79c99ecee8b7a&authtype=sso&custid=ns315887.

APA

Qunfang Yang, Tao Liu, Haiping Zheng, Zechen Zhou, Yan Huang, Honglin Jia, Shixiang Fu, Xuan Zhang, Haigang Zhang, Ya Liu, Xiaohong Chen, & Wenjun Shan. (2022). A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy. Biomaterials, 292.

Chicago

Qunfang Yang, Tao Liu, Haiping Zheng, Zechen Zhou, Yan Huang, Honglin Jia, Shixiang Fu, et al. 2022. “A Nanoformulation for Immunosuppression Reversal and Broad-Spectrum Self-Amplifying Antitumor Ferroptosis-Immunotherapy.” Biomaterials 292 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f66ad1ab4f54129408c79c99ecee8b7a&authtype=sso&custid=ns315887.